| 2026-06-05 |
SCHEDULE 13G/A |
QGEN
/ Qiagen N.V.
|
Massachusetts Financial Services Co /ma/
|
25,301,124 |
12,447,526 |
-50.80 |
| 2026-06-05 |
SCHEDULE 13G/A |
APLS
/ Apellis Pharmaceuticals
|
Morgan Stanley
|
9,592,751 |
0 |
-100.00 |
| 2026-06-05 |
SCHEDULE 13G/A |
TERN
/ Terns Pharmaceuticals
|
Morgan Stanley
|
6,433,964 |
0 |
-100.00 |
| 2026-06-05 |
SCHEDULE 13G |
RLYB
/ Rallybio
|
ADAR1 Capital Management, LLC
|
|
926,352 |
|
| 2026-06-05 |
SCHEDULE 13G |
INM
/ InMed Pharmaceuticals
|
ADAR1 Capital Management, LLC
|
|
800,000 |
|
| 2026-06-05 |
SCHEDULE 13G |
MGNX
/ MacroGenics
|
Millennium Management Llc
|
3,066,926 |
3,435,504 |
12.02 |
| 2026-06-05 |
SCHEDULE 13G/A |
CABA
/ Cabaletta Bio
|
Prudential Financial Inc
|
12,584,537 |
24,267,980 |
92.84 |
| 2026-06-05 |
SCHEDULE 13G/A |
IMMX
/ Immix Biopharma
|
Janus Henderson Group Plc
|
4,802,002 |
9,090,732 |
89.31 |
| 2026-06-05 |
SCHEDULE 13G |
CLRB
/ Cellectar Biosciences
|
Janus Henderson Group Plc
|
|
798,382 |
|
| 2026-06-05 |
13F-HR/A |
MRK
/ Merck
|
Oddo Bhf Asset Management Sas
|
88,425 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
LIN
/ Linde
|
Oddo Bhf Asset Management Sas
|
20,864 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
ELF
/ e.l.f. Beauty
|
Oddo Bhf Asset Management Sas
|
7,410 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
CHD
/ Church & Dwight
|
Oddo Bhf Asset Management Sas
|
65,739 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
AMGN
/ Amgen
|
Oddo Bhf Asset Management Sas
|
12,311 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
TSVT
/ 2seventy bio
|
Oddo Bhf Asset Management Sas
|
|
110,608 |
|
| 2026-06-05 |
13F-HR/A |
RDUS
/ Radius Recycling
|
Oddo Bhf Asset Management Sas
|
|
231,710 |
|
| 2026-06-05 |
13F-HR/A |
CKPT
/ Checkpoint Therapeutics
|
Oddo Bhf Asset Management Sas
|
|
2,175,000 |
|
| 2026-06-05 |
13F-HR/A |
IDXX
/ IDEXX Laboratories
|
Oddo Bhf Asset Management Sas
|
2,257 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
MRNS
/ Marinus Pharmaceuticals
|
Oddo Bhf Asset Management Sas
|
2,700,000 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
TECH
/ Bio-Techne
|
Oddo Bhf Asset Management Sas
|
15,033 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
CDMO
/ Avid Bioservices
|
Oddo Bhf Asset Management Sas
|
829,300 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
RVNC
/ Revance Therapeutics
|
Oddo Bhf Asset Management Sas
|
5,100,000 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Oddo Bhf Asset Management Sas
|
2,503 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Oddo Bhf Asset Management Sas
|
17,773 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
ABBV
/ AbbVie
|
Oddo Bhf Asset Management Sas
|
30,378 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
ROG
/ Rogers
|
Oddo Bhf Asset Management Sas
|
155,000 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
CE
/ Celanese
|
Oddo Bhf Asset Management Sas
|
7,614 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
TWST
/ Twist Bioscience
|
Oddo Bhf Asset Management Sas
|
52,837 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
ECL
/ Ecolab
|
Oddo Bhf Asset Management Sas
|
7,624 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
ARGX
/ argenx SE - Depositary Receipt
|
Oddo Bhf Asset Management Sas
|
19,401 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
REGN
/ Regeneron Pharmaceuticals
|
Oddo Bhf Asset Management Sas
|
1,057 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
UTHR
/ United Therapeutics
|
Oddo Bhf Asset Management Sas
|
2,124 |
0 |
-100.00 |
| 2026-06-05 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Oddo Bhf Asset Management Sas
|
31,969 |
0 |
-100.00 |
| 2026-06-05 |
SCHEDULE 13G/A |
KPTI
/ Karyopharm Therapeutics
|
T. Rowe Price Investment Management, Inc.
|
2,244,421 |
1,539,147 |
-31.42 |
| 2026-06-05 |
SCHEDULE 13G/A |
TENX
/ Tenax Therapeutics
|
Price T Rowe Associates Inc /md/
|
2,951,116 |
586,990 |
-80.11 |
| 2026-06-05 |
SCHEDULE 13G/A |
ELOXD
/ Eloxx Pharmaceuticals
|
Domicilium Real Estate Fund III LP
|
|
23,478 |
|
| 2026-06-05 |
SCHEDULE 13G/A |
BIIB
/ Biogen
|
Fmr Llc
|
9,413,062 |
16,652,974 |
76.91 |
| 2026-06-05 |
SCHEDULE 13G/A |
ATYR
/ aTyr Pharma
|
Fmr Llc
|
8,784,009 |
5,935,900 |
-32.42 |
| 2026-06-05 |
SCHEDULE 13G/A |
AVTX
/ Avalo Therapeutics
|
Fmr Llc
|
2,879,481 |
3,188,401 |
10.73 |
| 2026-06-05 |
SCHEDULE 13G/A |
EPC
/ Edgewell Personal Care
|
American Century Investment Management Inc
|
3,950,190 |
5,057,505 |
28.03 |
| 2026-06-04 |
SCHEDULE 13D/A |
AUPH
/ Aurinia Pharmaceuticals
|
Tang Capital Management Llc
|
12,229,500 |
13,044,106 |
6.66 |
| 2026-06-04 |
SCHEDULE 13G/A |
NAMS
/ NewAmsterdam Pharma Company N.V.
|
Capital World Investors
|
9,822,711 |
12,188,377 |
24.08 |
| 2026-06-04 |
13F-HR |
BINC
/ BlackRock ETF Trust II - iShares Flexible Income Active ETF
|
Town Capital LLC
|
26,501 |
36,430 |
37.47 |
| 2026-06-04 |
13F-HR |
BINC
/ BlackRock ETF Trust II - iShares Flexible Income Active ETF
|
Town Capital LLC
|
|
26,501 |
|
| 2026-06-04 |
SCHEDULE 13G |
QTTB
/ Q32 Bio
|
Biotechnology Value Fund L P
|
|
2,367,524 |
|
| 2026-06-04 |
13F-HR/A |
MIST
/ Milestone Pharmaceuticals
|
Seven Fleet Capital Management LP
|
|
333,333 |
|
| 2026-06-04 |
13F-HR/A |
PRTA
/ Prothena
|
Seven Fleet Capital Management LP
|
43,300 |
43,300 |
0.00 |
| 2026-06-04 |
13F-HR/A |
VYGR
/ Voyager Therapeutics
|
Seven Fleet Capital Management LP
|
|
115,203 |
|
| 2026-06-04 |
13F-HR/A |
LPCN
/ Lipocine
|
Seven Fleet Capital Management LP
|
|
124,942 |
|
| 2026-06-04 |
13F-HR/A |
IDYA
/ IDEAYA Biosciences
|
Seven Fleet Capital Management LP
|
|
86,283 |
|
| 2026-06-04 |
13F-HR/A |
ROIV
/ Roivant Sciences
|
Seven Fleet Capital Management LP
|
|
128,168 |
|
| 2026-06-04 |
13F-HR/A |
CCCC
/ C4 Therapeutics
|
Seven Fleet Capital Management LP
|
|
57,076 |
|
| 2026-06-04 |
13F-HR/A |
FULC
/ Fulcrum Therapeutics
|
Seven Fleet Capital Management LP
|
|
38,100 |
|
| 2026-06-04 |
13F-HR/A |
MGNX
/ MacroGenics
|
Seven Fleet Capital Management LP
|
|
13,387 |
|
| 2026-06-04 |
13F-HR/A |
IRON
/ Disc Medicine
|
Seven Fleet Capital Management LP
|
|
3,231 |
|
| 2026-06-04 |
13F-HR/A |
ALKS
/ Alkermes
|
Seven Fleet Capital Management LP
|
|
24,170 |
|
| 2026-06-04 |
13F-HR/A |
ERAS
/ Erasca
|
Seven Fleet Capital Management LP
|
|
222,468 |
|
| 2026-06-04 |
13F-HR/A |
AVBP
/ ArriVent BioPharma
|
Seven Fleet Capital Management LP
|
|
50,252 |
|
| 2026-06-04 |
13F-HR/A |
GPCR
/ Structure Therapeutics Inc. - Depositary Receipt
|
Seven Fleet Capital Management LP
|
|
9,000 |
|
| 2026-06-04 |
13F-HR/A |
AXSM
/ Axsome Therapeutics
|
Seven Fleet Capital Management LP
|
12,955 |
14,055 |
8.49 |
| 2026-06-04 |
13F-HR/A |
PALI
/ Palisade Bio
|
Seven Fleet Capital Management LP
|
327,500 |
213,100 |
-34.93 |
| 2026-06-04 |
13F-HR/A |
CNTX
/ Context Therapeutics
|
Seven Fleet Capital Management LP
|
|
190,785 |
|
| 2026-06-04 |
13F-HR/A |
RVMD
/ Revolution Medicines
|
Seven Fleet Capital Management LP
|
65,800 |
80,792 |
22.78 |
| 2026-06-04 |
13F-HR/A |
CRVS
/ Corvus Pharmaceuticals
|
Seven Fleet Capital Management LP
|
|
82,890 |
|
| 2026-06-04 |
13F-HR/A |
IPSC
/ Century Therapeutics
|
Seven Fleet Capital Management LP
|
|
2,947,826 |
|
| 2026-06-04 |
13F-HR/A |
ZNTL
/ Zentalis Pharmaceuticals
|
Seven Fleet Capital Management LP
|
|
110,000 |
|
| 2026-06-04 |
13F-HR/A |
MDGL
/ Madrigal Pharmaceuticals
|
Seven Fleet Capital Management LP
|
1,860 |
3,393 |
82.42 |
| 2026-06-04 |
13F-HR/A |
QURE
/ uniQure N.V.
|
Seven Fleet Capital Management LP
|
8,742 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
ACRS
/ Aclaris Therapeutics
|
Seven Fleet Capital Management LP
|
107,419 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
ALXO
/ ALX Oncology Holdings
|
Seven Fleet Capital Management LP
|
117,817 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
VRDN
/ Viridian Therapeutics
|
Seven Fleet Capital Management LP
|
14,654 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
EXEL
/ Exelixis
|
Seven Fleet Capital Management LP
|
68,569 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
ELDN
/ Eledon Pharmaceuticals
|
Seven Fleet Capital Management LP
|
6,000 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
IMUX
/ Immunic
|
Seven Fleet Capital Management LP
|
155,223 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
PLRX
/ Pliant Therapeutics
|
Seven Fleet Capital Management LP
|
276,500 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
NRIX
/ Nurix Therapeutics
|
Seven Fleet Capital Management LP
|
20,000 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
VIR
/ Vir Biotechnology
|
Seven Fleet Capital Management LP
|
200 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
VKTX
/ Viking Therapeutics
|
Seven Fleet Capital Management LP
|
6,000 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
CDTX
/ Cidara Therapeutics
|
Seven Fleet Capital Management LP
|
3,026 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
PRAX
/ Praxis Precision Medicines
|
Seven Fleet Capital Management LP
|
2,700 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
RGC
/ Regencell Bioscience Holdings
|
Seven Fleet Capital Management LP
|
4,400 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
ENTA
/ Enanta Pharmaceuticals
|
Seven Fleet Capital Management LP
|
2,270 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
TERN
/ Terns Pharmaceuticals
|
Seven Fleet Capital Management LP
|
130,413 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
TYRA
/ Tyra Biosciences
|
Seven Fleet Capital Management LP
|
79,560 |
195,685 |
145.96 |
| 2026-06-04 |
13F-HR/A |
PTGX
/ Protagonist Therapeutics
|
Seven Fleet Capital Management LP
|
8,000 |
4,000 |
-50.00 |
| 2026-06-04 |
13F-HR/A |
SLN
/ Silence Therapeutics plc - Depositary Receipt
|
Seven Fleet Capital Management LP
|
147,600 |
156,759 |
6.21 |
| 2026-06-04 |
13F-HR/A |
CGEM
/ Cullinan Therapeutics
|
Seven Fleet Capital Management LP
|
3,000 |
1,844 |
-38.53 |
| 2026-06-04 |
13F-HR/A |
CRBP
/ Corbus Pharmaceuticals Holdings
|
Seven Fleet Capital Management LP
|
56,750 |
85,687 |
50.99 |
| 2026-06-04 |
13F-HR/A |
XNCR
/ Xencor
|
Seven Fleet Capital Management LP
|
109,554 |
80,000 |
-26.98 |
| 2026-06-04 |
13F-HR/A |
IRD
/ Opus Genetics
|
Seven Fleet Capital Management LP
|
|
134,242 |
|
| 2026-06-04 |
13F-HR/A |
CATX
/ Perspective Therapeutics
|
Seven Fleet Capital Management LP
|
|
379,082 |
|
| 2026-06-04 |
13F-HR/A |
DRUG
/ Bright Minds Biosciences
|
Seven Fleet Capital Management LP
|
|
6,395 |
|
| 2026-06-04 |
13F-HR/A |
ABVX
/ ABIVAX Société Anonyme - Depositary Receipt
|
Seven Fleet Capital Management LP
|
13,499 |
43,052 |
218.93 |
| 2026-06-04 |
13F-HR/A |
ASMB
/ Assembly Biosciences
|
Seven Fleet Capital Management LP
|
73,762 |
56,147 |
-23.88 |
| 2026-06-04 |
13F-HR/A |
CGON
/ CG Oncology
|
Seven Fleet Capital Management LP
|
1,515,151 |
75,758 |
-95.00 |
| 2026-06-04 |
13F-HR/A |
UTHR
/ United Therapeutics
|
Seven Fleet Capital Management LP
|
1,300 |
1,128 |
-13.23 |
| 2026-06-04 |
13F-HR/A |
OCUL
/ Ocular Therapeutix
|
Seven Fleet Capital Management LP
|
17,100 |
31,296 |
83.02 |
| 2026-06-04 |
13F-HR/A |
COGT
/ Cogent Biosciences
|
Seven Fleet Capital Management LP
|
214,099 |
149,399 |
-30.22 |
| 2026-06-04 |
13F-HR/A |
EOLS
/ Evolus
|
Seven Fleet Capital Management LP
|
82,000 |
78,057 |
-4.81 |
| 2026-06-04 |
13F-HR/A |
RLAY
/ Relay Therapeutics
|
Seven Fleet Capital Management LP
|
73,000 |
257,738 |
253.07 |
| 2026-06-04 |
13F-HR/A |
CTMX
/ CytomX Therapeutics
|
Seven Fleet Capital Management LP
|
48,898 |
371,398 |
659.54 |
| 2026-06-04 |
13F-HR/A |
AMLX
/ Amylyx Pharmaceuticals
|
Seven Fleet Capital Management LP
|
11,571 |
16,671 |
44.08 |
| 2026-06-04 |
13F-HR/A |
NKTR
/ Nektar Therapeutics
|
Seven Fleet Capital Management LP
|
15,000 |
4,300 |
-71.33 |
| 2026-06-04 |
13F-HR/A |
AGIO
/ Agios Pharmaceuticals
|
Seven Fleet Capital Management LP
|
31,738 |
209,547 |
560.24 |
| 2026-06-04 |
13F-HR/A |
DNTH
/ Dianthus Therapeutics
|
Seven Fleet Capital Management LP
|
14,651 |
54,258 |
270.34 |
| 2026-06-04 |
13F-HR/A |
IKT
/ Inhibikase Therapeutics
|
Seven Fleet Capital Management LP
|
533,648 |
325,600 |
-38.99 |
| 2026-06-04 |
13F-HR/A |
MLYS
/ Mineralys Therapeutics
|
Seven Fleet Capital Management LP
|
42,025 |
69,571 |
65.55 |
| 2026-06-04 |
13F-HR/A |
GERN
/ Geron
|
Seven Fleet Capital Management LP
|
777,880 |
424,180 |
-45.47 |
| 2026-06-04 |
13F-HR/A |
CMPS
/ COMPASS Pathways plc - Depositary Receipt
|
Seven Fleet Capital Management LP
|
40,000 |
158,021 |
295.05 |
| 2026-06-04 |
13F-HR/A |
KALV
/ KalVista Pharmaceuticals
|
Seven Fleet Capital Management LP
|
48,412 |
128,487 |
165.40 |
| 2026-06-04 |
13F-HR/A |
PMVP
/ PMV Pharmaceuticals
|
Seven Fleet Capital Management LP
|
63,498 |
63,498 |
0.00 |
| 2026-06-04 |
13F-HR/A |
TSHA
/ Taysha Gene Therapies
|
Seven Fleet Capital Management LP
|
167,223 |
625,708 |
274.18 |
| 2026-06-04 |
13F-HR/A |
CLYM
/ Climb Bio
|
Seven Fleet Capital Management LP
|
76,400 |
130,654 |
71.01 |
| 2026-06-04 |
13F-HR/A |
NERV
/ Minerva Neurosciences
|
Seven Fleet Capital Management LP
|
|
248,476 |
|
| 2026-06-04 |
13F-HR/A |
VSTM
/ Verastem
|
Seven Fleet Capital Management LP
|
15,140 |
123,400 |
715.06 |
| 2026-06-04 |
13F-HR/A |
SVRA
/ Savara
|
Seven Fleet Capital Management LP
|
62,762 |
295,688 |
371.13 |
| 2026-06-04 |
13F-HR/A |
PHVS
/ Pharvaris N.V.
|
Seven Fleet Capital Management LP
|
55,342 |
172,731 |
212.12 |
| 2026-06-04 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Seven Fleet Capital Management LP
|
|
720 |
|
| 2026-06-04 |
13F-HR/A |
PMN
/ ProMIS Neurosciences
|
Seven Fleet Capital Management LP
|
|
10,600 |
|
| 2026-06-04 |
13F-HR/A |
IVA
/ Inventiva S.A. - Depositary Receipt
|
Seven Fleet Capital Management LP
|
|
200,141 |
|
| 2026-06-04 |
13F-HR/A |
GLTO
/ Damora Therapeutics
|
Seven Fleet Capital Management LP
|
|
101,248 |
|
| 2026-06-04 |
13F-HR/A |
ENTX
/ Entera Bio
|
Seven Fleet Capital Management LP
|
135,318 |
205,542 |
51.90 |
| 2026-06-04 |
13F-HR/A |
KRYS
/ Krystal Biotech
|
Seven Fleet Capital Management LP
|
4,000 |
4,316 |
7.90 |
| 2026-06-04 |
13F-HR/A |
CLDX
/ Celldex Therapeutics
|
Seven Fleet Capital Management LP
|
|
29,300 |
|
| 2026-06-04 |
13F-HR/A |
SABS
/ SAB Biotherapeutics
|
Seven Fleet Capital Management LP
|
|
100,000 |
|
| 2026-06-04 |
13F-HR/A |
CYTK
/ Cytokinetics
|
Seven Fleet Capital Management LP
|
10,335 |
61,269 |
492.83 |
| 2026-06-04 |
13F-HR/A |
DNLI
/ Denali Therapeutics
|
Seven Fleet Capital Management LP
|
|
35,286 |
|
| 2026-06-04 |
13F-HR/A |
UNCY
/ Unicycive Therapeutics
|
Seven Fleet Capital Management LP
|
|
55,700 |
|
| 2026-06-04 |
13F-HR/A |
ZLAB
/ Zai Lab Limited - Depositary Receipt
|
Seven Fleet Capital Management LP
|
|
77,858 |
|
| 2026-06-04 |
13F-HR/A |
BCRX
/ BioCryst Pharmaceuticals
|
Seven Fleet Capital Management LP
|
|
102,493 |
|
| 2026-06-04 |
13F-HR/A |
REPL
/ Replimune Group
|
Seven Fleet Capital Management LP
|
|
120,400 |
|
| 2026-06-04 |
13F-HR/A |
LRMR
/ Larimar Therapeutics
|
Seven Fleet Capital Management LP
|
|
256,585 |
|
| 2026-06-04 |
13F-HR/A |
SYRE
/ Spyre Therapeutics
|
Seven Fleet Capital Management LP
|
|
19,690 |
|
| 2026-06-04 |
13F-HR/A |
PCVX
/ Vaxcyte
|
Seven Fleet Capital Management LP
|
25,365 |
108,450 |
327.56 |
| 2026-06-04 |
13F-HR/A |
MNMD
/ Mind Medicine
|
Seven Fleet Capital Management LP
|
|
99,887 |
|
| 2026-06-04 |
13F-HR/A |
PEPG
/ PepGen
|
Seven Fleet Capital Management LP
|
|
59,500 |
|
| 2026-06-04 |
13F-HR/A |
NTLA
/ Intellia Therapeutics
|
Seven Fleet Capital Management LP
|
|
31,500 |
|
| 2026-06-04 |
13F-HR/A |
WHWK
/ Whitehawk Therapeutics
|
Seven Fleet Capital Management LP
|
|
54,296 |
|
| 2026-06-04 |
13F-HR/A |
ATXS
/ Astria Therapeutics
|
Seven Fleet Capital Management LP
|
4,000 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
TRAW
/ Traws Pharma
|
Seven Fleet Capital Management LP
|
49,260 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
RLMD
/ Relmada Therapeutics
|
Seven Fleet Capital Management LP
|
154,109 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
GBIO
/ Generation Bio
|
Seven Fleet Capital Management LP
|
5,376 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
NAMS
/ NewAmsterdam Pharma Company N.V.
|
Seven Fleet Capital Management LP
|
4,000 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
ZURA
/ Zura Bio
|
Seven Fleet Capital Management LP
|
166,500 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
VTGN
/ Vistagen Therapeutics
|
Seven Fleet Capital Management LP
|
62,701 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
FOLD
/ Amicus Therapeutics
|
Seven Fleet Capital Management LP
|
82,500 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
TNGX
/ Tango Therapeutics
|
Seven Fleet Capital Management LP
|
215,172 |
502,012 |
133.31 |
| 2026-06-04 |
13F-HR/A |
IPSC
/ Century Therapeutics
|
Seven Fleet Capital Management LP
|
|
1,400,000 |
|
| 2026-06-04 |
13F-HR/A |
CGON
/ CG Oncology
|
Seven Fleet Capital Management LP
|
1,515,151 |
1,439,393 |
-5.00 |
| 2026-06-04 |
13F-HR/A |
CMPX
/ Compass Therapeutics
|
Seven Fleet Capital Management LP
|
568,747 |
423,566 |
-25.53 |
| 2026-06-04 |
13F-HR/A |
CTMX
/ CytomX Therapeutics
|
Seven Fleet Capital Management LP
|
48,898 |
714,000 |
1,360.18 |
| 2026-06-04 |
13F-HR/A |
DNTH
/ Dianthus Therapeutics
|
Seven Fleet Capital Management LP
|
14,651 |
26,551 |
81.22 |
| 2026-06-04 |
13F-HR/A |
ELVN
/ Enliven Therapeutics
|
Seven Fleet Capital Management LP
|
99,953 |
95,253 |
-4.70 |
| 2026-06-04 |
13F-HR/A |
SLNO
/ Soleno Therapeutics
|
Seven Fleet Capital Management LP
|
130,079 |
54,000 |
-58.49 |
| 2026-06-04 |
13F-HR/A |
TNGX
/ Tango Therapeutics
|
Seven Fleet Capital Management LP
|
215,172 |
300,648 |
39.72 |
| 2026-06-04 |
13F-HR/A |
TYRA
/ Tyra Biosciences
|
Seven Fleet Capital Management LP
|
79,560 |
2,900 |
-96.35 |
| 2026-06-04 |
13F-HR/A |
PCVX
/ Vaxcyte
|
Seven Fleet Capital Management LP
|
25,365 |
20,000 |
-21.15 |
| 2026-06-04 |
13F-HR/A |
INBX
/ Inhibrx Biosciences
|
Seven Fleet Capital Management LP
|
|
2,482 |
|
| 2026-06-04 |
13F-HR/A |
ZYME
/ Zymeworks
|
Seven Fleet Capital Management LP
|
20,600 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
GLUE
/ Monte Rosa Therapeutics
|
Seven Fleet Capital Management LP
|
4,000 |
22,530 |
463.25 |
| 2026-06-04 |
13F-HR/A |
LQDA
/ Liquidia
|
Seven Fleet Capital Management LP
|
91,267 |
187,876 |
105.85 |
| 2026-06-04 |
13F-HR/A |
TRVI
/ Trevi Therapeutics
|
Seven Fleet Capital Management LP
|
7,110 |
27,149 |
281.84 |
| 2026-06-04 |
13F-HR/A |
CMPX
/ Compass Therapeutics
|
Seven Fleet Capital Management LP
|
568,747 |
516,972 |
-9.10 |
| 2026-06-04 |
13F-HR/A |
ASND
/ Ascendis Pharma A
|
Seven Fleet Capital Management LP
|
5,670 |
12,179 |
114.80 |
| 2026-06-04 |
13F-HR/A |
EWTX
/ Edgewise Therapeutics
|
Seven Fleet Capital Management LP
|
2,000 |
11,701 |
485.05 |
| 2026-06-04 |
13F-HR/A |
APGE
/ Apogee Therapeutics
|
Seven Fleet Capital Management LP
|
1,800 |
1,969 |
9.39 |
| 2026-06-04 |
13F-HR/A |
NUVL
/ Nuvalent
|
Seven Fleet Capital Management LP
|
12,601 |
2,072 |
-83.56 |
| 2026-06-04 |
13F-HR/A |
AVTX
/ Avalo Therapeutics
|
Seven Fleet Capital Management LP
|
63,343 |
213,819 |
237.56 |
| 2026-06-04 |
13F-HR/A |
BEAM
/ Beam Therapeutics
|
Seven Fleet Capital Management LP
|
9,537 |
8,804 |
-7.69 |
| 2026-06-04 |
13F-HR/A |
SLNO
/ Soleno Therapeutics
|
Seven Fleet Capital Management LP
|
130,079 |
115,770 |
-11.00 |
| 2026-06-04 |
13F-HR/A |
ELVN
/ Enliven Therapeutics
|
Seven Fleet Capital Management LP
|
99,953 |
164,030 |
64.11 |
| 2026-06-04 |
13F-HR/A |
TARS
/ Tarsus Pharmaceuticals
|
Seven Fleet Capital Management LP
|
4,500 |
19,800 |
340.00 |
| 2026-06-04 |
13F-HR/A |
LONA
/ LeonaBio
|
Seven Fleet Capital Management LP
|
127,951 |
164,676 |
28.70 |
| 2026-06-04 |
SCHEDULE 13G |
QTTB
/ Q32 Bio
|
Ra Capital Management, L.p.
|
|
2,332,457 |
|
| 2026-06-04 |
13F-HR/A |
SNY
/ Sanofi - Depositary Receipt
|
Chelsea Counsel Co
|
1,910 |
1,845 |
-3.40 |
| 2026-06-04 |
13F-HR/A |
BINC
/ BlackRock ETF Trust II - iShares Flexible Income Active ETF
|
Chelsea Counsel Co
|
26 |
0 |
-100.00 |
| 2026-06-04 |
13F-HR/A |
GILD
/ Gilead Sciences
|
Chelsea Counsel Co
|
4 |
4 |
0.00 |
| 2026-06-04 |
13F-HR/A |
GJR
/ Strats Trust For Procter & Gambel Security - Preferred Security
|
Chelsea Counsel Co
|
19,883 |
19,883 |
0.00 |
| 2026-06-04 |
13F-HR/A |
AMGN
/ Amgen
|
Chelsea Counsel Co
|
10,874 |
9,374 |
-13.79 |
| 2026-06-04 |
13F-HR/A |
APD
/ Air Products and Chemicals
|
Chelsea Counsel Co
|
1,847 |
1,797 |
-2.71 |
| 2026-06-04 |
13F-HR/A |
MRK
/ Merck
|
Chelsea Counsel Co
|
3,260 |
2,840 |
-12.88 |
| 2026-06-04 |
13F-HR/A |
ECL
/ Ecolab
|
Chelsea Counsel Co
|
780 |
780 |
0.00 |
| 2026-06-04 |
13F-HR/A |
ABT
/ Abbott Laboratories
|
Chelsea Counsel Co
|
21,311 |
16,311 |
-23.46 |
| 2026-06-04 |
13F-HR/A |
CTXR
/ Citius Pharmaceuticals
|
Chelsea Counsel Co
|
4,626 |
4,626 |
0.00 |
| 2026-06-04 |
13F-HR/A |
NVO
/ Novo Nordisk A
|
Chelsea Counsel Co
|
500 |
500 |
0.00 |
| 2026-06-04 |
13F-HR/A |
UL
/ Unilever PLC - Depositary Receipt
|
Chelsea Counsel Co
|
354 |
354 |
0.00 |
| 2026-06-04 |
13F-HR/A |
ABBV
/ AbbVie
|
Chelsea Counsel Co
|
114 |
114 |
0.00 |
| 2026-06-04 |
13F-HR/A |
MRNA
/ Moderna
|
Chelsea Counsel Co
|
100 |
100 |
0.00 |
| 2026-06-04 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Chelsea Counsel Co
|
381 |
351 |
-7.87 |
| 2026-06-04 |
13F-HR/A |
KVUE
/ Kenvue
|
Chelsea Counsel Co
|
17,799 |
17,799 |
0.00 |
| 2026-06-04 |
13F-HR/A |
HXL
/ Hexcel
|
Chelsea Counsel Co
|
33,210 |
27,140 |
-18.28 |
| 2026-06-04 |
13F-HR/A |
PFE
/ Pfizer
|
Chelsea Counsel Co
|
0 |
20,000 |
|
| 2026-06-04 |
13F-HR/A |
MOS
/ Mosaic
|
Chelsea Counsel Co
|
1,000 |
1,000 |
0.00 |
| 2026-06-04 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Chelsea Counsel Co
|
150 |
150 |
0.00 |
| 2026-06-04 |
13F-HR/A |
CL
/ Colgate-Palmolive
|
Chelsea Counsel Co
|
5,500 |
5,500 |
0.00 |
| 2026-06-04 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Chelsea Counsel Co
|
21,544 |
18,241 |
-15.33 |
| 2026-06-04 |
13F-HR/A |
NTR
/ Nutrien
|
Chelsea Counsel Co
|
1,520 |
1,500 |
-1.32 |
| 2026-06-04 |
SCHEDULE 13G/A |
CABA
/ Cabaletta Bio
|
Jennison Associates Llc
|
12,584,537 |
24,267,980 |
92.84 |
| 2026-06-04 |
13F-HR |
ABT
/ Abbott Laboratories
|
Evansbrook LLC
|
3,305 |
3,196 |
-3.30 |
| 2026-06-04 |
13F-HR |
APD
/ Air Products and Chemicals
|
Evansbrook LLC
|
1,722 |
1,722 |
0.00 |
| 2026-06-04 |
13F-HR |
GJR
/ Strats Trust For Procter & Gambel Security - Preferred Security
|
Evansbrook LLC
|
6,518 |
6,663 |
2.22 |
| 2026-06-04 |
13F-HR |
PPG
/ PPG Industries
|
Evansbrook LLC
|
3,259 |
3,259 |
0.00 |
| 2026-06-04 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Evansbrook LLC
|
8,571 |
8,612 |
0.48 |
| 2026-06-04 |
13F-HR |
LLY
/ Eli Lilly and
|
Evansbrook LLC
|
1,359 |
1,445 |
6.33 |
| 2026-06-04 |
13F-HR |
ABBV
/ AbbVie
|
Evansbrook LLC
|
3,482 |
3,531 |
1.41 |
| 2026-06-04 |
13F-HR |
LIN
/ Linde
|
Evansbrook LLC
|
|
459 |
|
| 2026-06-04 |
13F-HR |
MRK
/ Merck
|
Evansbrook LLC
|
2,309 |
2,367 |
2.51 |
| 2026-06-04 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Evansbrook LLC
|
5,382 |
5,453 |
1.32 |
| 2026-06-04 |
SCHEDULE 13G/A |
RGNX
/ REGENXBIO
|
Jpmorgan Chase & Co
|
3,698,862 |
2,279,362 |
-38.38 |
| 2026-06-03 |
13F-HR |
APD
/ Air Products and Chemicals
|
Peak Planning Group, LLC
|
784 |
897 |
14.41 |
| 2026-06-03 |
13F-HR |
AMGN
/ Amgen
|
Peak Planning Group, LLC
|
972 |
1,001 |
2.98 |
| 2026-06-03 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Peak Planning Group, LLC
|
|
1,582 |
|
| 2026-06-03 |
13F-HR |
ABBV
/ AbbVie
|
Peak Planning Group, LLC
|
3,823 |
3,836 |
0.34 |
| 2026-06-03 |
13F-HR |
MRK
/ Merck
|
Peak Planning Group, LLC
|
2,506 |
2,686 |
7.18 |
| 2026-06-03 |
SCHEDULE 13G/A |
UNOV
/ Innovator ETFs Trust - Innovator U.S. Equity Ultra Buffer ETF - November
|
Brookstone Capital Management
|
1,679,076 |
79,564 |
-95.26 |
| 2026-06-03 |
13F-HR/A |
PFE
/ Pfizer
|
Wealthquest Corp
|
18,420 |
20,683 |
12.29 |
| 2026-06-03 |
13F-HR/A |
APD
/ Air Products and Chemicals
|
Wealthquest Corp
|
3,357 |
3,363 |
0.18 |
| 2026-06-03 |
13F-HR/A |
GJR
/ Strats Trust For Procter & Gambel Security - Preferred Security
|
Wealthquest Corp
|
186,823 |
194,479 |
4.10 |
| 2026-06-03 |
13F-HR/A |
ABBV
/ AbbVie
|
Wealthquest Corp
|
3,404 |
3,618 |
6.29 |
| 2026-06-03 |
13F-HR/A |
LIN
/ Linde
|
Wealthquest Corp
|
937 |
993 |
5.98 |
| 2026-06-03 |
13F-HR/A |
ABT
/ Abbott Laboratories
|
Wealthquest Corp
|
7,122 |
7,835 |
10.01 |
| 2026-06-03 |
13F-HR/A |
MRK
/ Merck
|
Wealthquest Corp
|
17,556 |
18,066 |
2.90 |
| 2026-06-03 |
13F-HR/A |
AMGN
/ Amgen
|
Wealthquest Corp
|
3,374 |
3,002 |
-11.03 |
| 2026-06-03 |
13F-HR/A |
BMY
/ Bristol-Myers Squibb
|
Wealthquest Corp
|
5,760 |
5,871 |
1.93 |
| 2026-06-03 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Wealthquest Corp
|
5,441 |
5,519 |
1.43 |
| 2026-06-03 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Wealthquest Corp
|
9,076 |
10,152 |
11.86 |
| 2026-06-03 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt
|
CoreFirst Bank & Trust
|
40 |
0 |
-100.00 |
| 2026-06-03 |
13F-HR |
CL
/ Colgate-Palmolive
|
CoreFirst Bank & Trust
|
110,082 |
110,082 |
0.00 |
| 2026-06-03 |
13F-HR |
LIN
/ Linde
|
CoreFirst Bank & Trust
|
90 |
15 |
-83.33 |
| 2026-06-03 |
13F-HR |
DD
/ DuPont de Nemours
|
CoreFirst Bank & Trust
|
926 |
926 |
0.00 |
| 2026-06-03 |
13F-HR |
ABT
/ Abbott Laboratories
|
CoreFirst Bank & Trust
|
2,538 |
2,538 |
0.00 |
| 2026-06-03 |
13F-HR |
PPG
/ PPG Industries
|
CoreFirst Bank & Trust
|
500 |
500 |
0.00 |
| 2026-06-03 |
13F-HR |
CLX
/ Clorox
|
CoreFirst Bank & Trust
|
410 |
410 |
0.00 |
| 2026-06-03 |
13F-HR |
MRK
/ Merck
|
CoreFirst Bank & Trust
|
9,599 |
8,902 |
-7.26 |
| 2026-06-03 |
13F-HR |
NVS
/ Novartis AG - Depositary Receipt
|
CoreFirst Bank & Trust
|
3,450 |
3,490 |
1.16 |
| 2026-06-03 |
13F-HR |
AMGN
/ Amgen
|
CoreFirst Bank & Trust
|
2,903 |
2,633 |
-9.30 |
| 2026-06-03 |
13F-HR |
DOW
/ Dow
|
CoreFirst Bank & Trust
|
189 |
189 |
0.00 |
| 2026-06-03 |
13F-HR |
NVO
/ Novo Nordisk A
|
CoreFirst Bank & Trust
|
4,723 |
4,723 |
0.00 |
| 2026-06-03 |
13F-HR |
JAZZ
/ Jazz Pharmaceuticals
|
CoreFirst Bank & Trust
|
225 |
225 |
0.00 |
| 2026-06-03 |
13F-HR |
OLN
/ Olin
|
CoreFirst Bank & Trust
|
22,670 |
22,780 |
0.49 |
| 2026-06-03 |
13F-HR |
BIIB
/ Biogen
|
CoreFirst Bank & Trust
|
590 |
295 |
-50.00 |
| 2026-06-03 |
13F-HR |
HUN
/ Huntsman
|
CoreFirst Bank & Trust
|
1,029 |
1,029 |
0.00 |
| 2026-06-03 |
13F-HR |
GJR
/ Strats Trust For Procter & Gambel Security - Preferred Security
|
CoreFirst Bank & Trust
|
11,417 |
11,417 |
0.00 |
| 2026-06-03 |
13F-HR |
ABBV
/ AbbVie
|
CoreFirst Bank & Trust
|
4,365 |
3,751 |
-14.07 |
| 2026-06-03 |
13F-HR |
LLY
/ Eli Lilly and
|
CoreFirst Bank & Trust
|
600 |
515 |
-14.17 |
| 2026-06-03 |
13F-HR |
WLK
/ Westlake
|
CoreFirst Bank & Trust
|
2,220 |
2,195 |
-1.13 |
| 2026-06-03 |
13F-HR |
PFE
/ Pfizer
|
CoreFirst Bank & Trust
|
4,497 |
3,811 |
-15.25 |
| 2026-06-03 |
13F-HR |
CHD
/ Church & Dwight
|
CoreFirst Bank & Trust
|
3,500 |
3,500 |
0.00 |